1. Li L, Zhuang L, Zhou J, Shao C. Pulmonary cryptococcosis coexisting with adenocarcinoma: a case report and review of the literature. J Med Case Rep 2018; 12: 327.
2. Hu M, Chai S, Lei W, Liao K, Zhang R. Mediastinal small cell carcinoma with primary cutaneous cryptococcosis: A rare case report. Infect Drug Resist 2021; 14: 3693-3697.
3. Ettahar N, Legout L, Ajana F, Patoz P, Massongo M, Rose C, et al. Cryptococcal osteomyelitis in a patient with a lymphocytic leukemia treated with fludarabine-cyclophosphamide-rituximab. J Mycol Med 2013; 23: 57-63.
4. Sato S, Kambe E, Tamai Y. Disseminated cryptococcosis in a patient with multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone. Intern Med 2019; 58: 843-847.
5. Vellayappan BA, Bharwani L. Cryptococcemia in a patient with glioblastoma: case report and literature review. Can J Neurol Sci 2012; 39: 852-854.
6. Zhang F, Li Y, Shen H, Tao J, Wang J. Case Report: Cryptococcal eosinophilic meningitis in a patient with Hodgkin lymphoma. Front Neurol 2022; 13: 898525.
7. Cunha Pereira T, Rb-Silva R, Félix Soares R, Domingues N, Mariz J. Case Report: Cryptococcal meningitis in Hodgkin’s lymphoma patient receiving brentuximab-vedotin therapy. F1000Res 2020; 9: 687.
8. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010; 50: 291-322.
9. Mundo W, Berning A, Koullias Y, Chastain DB, Stone N, Franco-Paredes C, et al. Disseminated cryptococcal disease in a patient with chronic chylothorax and a pleurovenous catheter, a case report with autopsy findings. Open Forum Infect Dis 2021; 8: ofab258.
10. Espinel-Ingroff A, Turnidge J. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds. Rev Iberoam Micol 2016; 33: 63-75.
11. Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc 2013; 124: 61-79.
12. Schmalzle SA, Buchwald UK, Gilliam BL, Riedel DJ. Cryptococcus neoformans infection in malignancy. Mycoses 2016; 59: 542-552.
13. Loyse A, Dromer F, Day J, Lortholary O, Harrison TS. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. J Antimicrob Chemother 2013; 68: 2435-2444.
14. Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of new agents. Microbiol Spectr 2016; 4: 10.1128/microbiolspec.FUNK-0002-2016.
15. Yigit N, Wu WW, Covey S, Tam W. Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma. Int J Hematol 2015; 101: 211-212.
16. Vanerwegen E, Ahmadi Bidakhvidi N, Vergote VKJ, Janssens A, Deroose CM. Cerebellar hypermetabolism in a Hodgkin Lymphoma leads to diagnosis of paucisymptomatic Cryptococcus neoformans meningitis. Clin Nucl Med 2023; 48(8): e374-e376.
17. McClelland EE, Hobbs LM, Rivera J, Casadevall A, Potts WK, Smith JM, et al. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One 2013; 8(5): e63632.